InBioGen Co Operating Expenses

Total Operating Expenses of InBioGen Co is 6.75 B KRW in 2026.

Total Operating Expenses of InBioGen Co changed from 7.48 B KRW to 6.75 B KRW, representing a -9.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses InBioGen Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's InBioGen Co historically and in real time.